Dutch Court maintains its October decision regarding the suspension of Nexperia's former CEO, will appoint two investigators at Nexperia on short notice

The Dutch Court's decision to uphold the suspension of Nexperia's former CEO, alongside the appointment of investigators, signals potential disruptions within the company, which could impact its operations and governance.

Newsquawk StaffPublished On the live feed at 2 more headlines followed before this page went public
Newsquawk headlinesUTC

Merck's (MRK) KEYTRUDA and KEYTRUDA QLEX plus Paclitaxel +/- Bevacizumab has been approved for certain adults with PD-L1+ platinum-resistant ovarian carcinoma as second or third line treatment

US President Trump is privately considering exiting the North American trade pact, Bloomberg reports

Dutch Court maintains its October decision regarding the suspension of Nexperia's former CEO, will appoint two investigators at Nexperia on short notice

Smurfit Westrock (SWR LN) Q4 (USD) Net Sales 7.58bln (prev. 7.53bln Y/Y), Adj. EPS 0.34 (prev. 0.47 Y/Y)

China State Council holds a session on boosting AI use; Chinese Premier Li urges promoting the use of AI in various sectors

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

Investors should monitor how this may affect Nexperia's trading activity and any broader implications for its partnerships and market perception.

Related headlines

The whole workspace, free to try.

Try it free